Successful pharmaco-invasive approach using a lower alteplase dose and VA-ECMO support in high-risk pulmonary embolism: case report

Paola Gutierrez-Gallegos,Vicente Jimenez-Franco,Carlos Jerjes-Sanchez,Renata Quevedo-Salazar,Jahir Rodriguez-Rivera,Enrique Paredes-Gutierrez,Daniel Lira-Lozano,Juan Quintanilla-Gutierrez,Rene Gomez-Gutierrez,Erasmo de la Peña-Almaguer,Guillermo Torre-Amione
DOI: https://doi.org/10.3389/fcvm.2024.1444636
2024-07-22
Abstract:Despite the elevated mortality rates associated with high-risk pulmonary embolism (PE), this condition remains understudied. Data regarding the effectiveness and safety of invasive therapies such as venoarterial extracorporeal membrane oxygenation (VA-ECMO) in this patient population remains controversial. Here, we present the case of a 61-year-old male with high-risk PE associated with refractory cardiac arrest and cardiogenic shock who underwent a combination of extracorporeal cardiopulmonary resuscitation with VA-ECMO and pharmaco-invasive therapy (mechanical thrombi fragmentation plus lower alteplase dose), resulting in successful pulmonary reperfusion. After a prolonged in-hospital stay, the patient was discharged in stable condition.
What problem does this paper attempt to address?